Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells

Liver cancer is the sixth most common cancer worldwide with high morbidity and mortality. Programmed death ligand 1 (PD-L1) is a major ligand of programmed death 1 receptor (PD1), and PD1/PD-L1 checkpoint acts as a negative regulator of the immune system. Cancers evade the host’s immune defense via...

Descripción completa

Detalles Bibliográficos
Autores principales: Shwe, Thuzar Hla, Pothacharoen, Peraphan, Phitak, Thanyaluck, Wudtiwai, Benjawan, Kongtawelert, Prachya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395726/
https://www.ncbi.nlm.nih.gov/pubmed/34445462
http://dx.doi.org/10.3390/ijms22168755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395726/
https://www.ncbi.nlm.nih.gov/pubmed/34445462
http://dx.doi.org/10.3390/ijms22168755

Ejemplares similares